Gene Therapies For Spinal Cord-Related Disorders With SwanBio's CSO
Source: Cell & Gene
Karen Kozarsky, Ph.D., Co-Founder and CSO of SwanBio explains how the company is pioneering a deep and varied pipeline of gene therapies for genetically defined neurological diseases with a focus on the spinal cord.
This website uses cookies to ensure you get the best experience on our website. Learn more